Patents Assigned to Certis Oncology Solutions, Inc.
  • Artificial intelligence for identifying one or more predictive biomarkers
    Patent number: 12254987
    Abstract: Methods and systems of using at least one hardware processor to train a machine learning algorithm to identify one or more predictive drug molecular features and/or predictive gene biomarkers for cancer treatment is provided. In some embodiments, the method uses at least one cancer drug discovery data set to train at least one learning algorithm in a prediction model, and uses a xenograft mouse model to validate the prediction model, with biological response fed back to the prediction model to further train the learning algorithm.
    Type: Grant
    Filed: March 23, 2023
    Date of Patent: March 18, 2025
    Assignee: Certis Oncology Solutions, Inc.
    Inventors: Long Hoang Do, Yuan Hung Chien, Peter Ellman